Jacobson Pharma’s Chairman Uplifts Shareholding to Above 60%
HONG KONG, Mar 14, 2022 – (ACN Newswire via SEAPRWire.com) – Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma Corporation Limited (the “Company”; together with its subsidiaries, the “Group”; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare... » read more